From the Journals

Phosphodiesterase-5 inhibitors often prescribed inappropriately

Publish date: March 9, 2018

 

FROM ANNALS OF THE AMERICAN THORACIC SOCIETY

SOURCE: Wiener RS et al. Ann Am Thorac Soc. 2018 Feb 27. doi: 10.1513/AnnalsATS.201710-762OC.

Pages

Recommended Reading

Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk
MDedge Cardiology
Phrenic-nerve stimulator maintains benefits for 18 months
MDedge Cardiology
Pulmonary hypertension treatment gets under the skin
MDedge Cardiology
Acute kidney injury linked with doubled inpatient VTEs
MDedge Cardiology
First month of LABA/LAMA ups cardiovascular risk
MDedge Cardiology
Influenza: All that and MI too
MDedge Cardiology
FDA approves implantable therapy for PAH
MDedge Cardiology
OSA may provide cardioprotection
MDedge Cardiology
Adenotonsillectomy reduced hypertension in OSA subgroup
MDedge Cardiology
NIAID proposes 3-pronged plan for universal influenza vaccine
MDedge Cardiology